MalDA, Accelerating Malaria Drug Discovery
© 2021 The Authors The Malaria Drug Accelerator (MalDA) is a consortium of 15 leading scientific laboratories. The aim of MalDA is to improve and accelerate the early antimalarial drug discovery process by identifying new, essential, druggable targets. In addition, it seeks to produce early lead inh...
Main Authors: | Yang, Tuo, Ottilie, Sabine, Istvan, Eva S, Godinez-Macias, Karla P, Lukens, Amanda K, Baragaña, Beatriz, Campo, Brice, Walpole, Chris, Niles, Jacquin C, Chibale, Kelly, Dechering, Koen J, Llinás, Manuel, Lee, Marcus CS, Kato, Nobutaka, Wyllie, Susan, McNamara, Case W, Gamo, Francisco Javier, Burrows, Jeremy, Fidock, David A, Goldberg, Daniel E, Gilbert, Ian H, Wirth, Dyann F, Winzeler, Elizabeth A |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2021
|
Online Access: | https://hdl.handle.net/1721.1/133583 |
Similar Items
-
MalDA, Accelerating Malaria Drug Discovery
by: Yang, Tuo, et al.
Published: (2022) -
Prioritization of Molecular Targets for Antimalarial Drug Discovery
by: Forte, Barbara, et al.
Published: (2023) -
In vivo profiles in malaria are consistent with a novel physiological state
by: Wirth, Dyann, et al.
Published: (2010) -
Plasmodium Niemann-Pick type C1-related protein is a druggable target required for parasite membrane homeostasis
by: Istvan, Eva S, et al.
Published: (2020) -
Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum
by: Dharia, Neekesh V, et al.
Published: (2010)